Rocco Montone
@roccomontone
MD, PhD, FESC โข Interventional Cardiologist & Intensive Cardiac Care @UniCatt @PoliclinicoGemelli Rome - Italy ๐ฎ๐น โข Assoc Editor #EHJ โข #SoMe Editor @escardio
ID: 594651538
https://www.linkedin.com/in/rocco-a-montone-md-phd-91a8171b/ 30-05-2012 14:46:18
534 Tweet
2,2K Followers
744 Following
A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriers. Discover more in #EHJ ๐ bit.ly/3YjZBNI Rocco Montone EHJ Editor-in-Chief
The presence of anti-NaV1.5 autoantibodies in the majority of patients with Brugada syndrome suggests an immunopathogenic component beyond genetic predispositions. Read more in #EHJ ๐ bit.ly/3WNuHvV Rocco Montone EHJ Editor-in-Chief
Coronary bypass surgery for multivessel disease after percutaneous coronary intervention in acute coronary syndromes: why, for whom, how early? A State-of-the-Art Review in #EHJ ๐ bit.ly/3YxQ3P7 Rocco Montone EHJ Editor-in-Chief
In the ISCHEMIA trial, total plaque volume assessed by coronary computed tomography angiography was associated with cardiovascular death or myocardial infarction at follow-up. Read more in #EHJ ๐ bit.ly/3WHGGdl Rocco Montone EHJ Editor-in-Chief
Anthracycline-induced cardiovascular toxicity: validation of the #HFA_ESC and International Cardio-Oncology Society risk score. Discover more in #EHJ ๐ bit.ly/3M0aTQ0 Rocco Montone EHJ Editor-in-Chief
The DanGer Shock trial: a new dawn but much to uncover. A Viewpoint just published in #EHJ dealing with the role of mechanical circulatory support in #cardiogenicshock ๐ bit.ly/4cqEmxf Rocco Montone EHJ Editor-in-Chief
The AORTA Gene score for detection and risk stratification of ascending aortic dilation. An interesting research article just published in #EHJ ๐ bit.ly/4fPb7Xx Rocco Montone EHJ Editor-in-Chief
Cardiovascular disease assessment and management in liver transplantation. An interesting and insightful review article just published in #EHJ ๐ bit.ly/3MgaHw8 Rocco Montone EHJ Editor-in-Chief
Are there sex-related differences in the clinical course of aortic root and ascending aortic aneurysms? Read the DisSEXion Study just published in #EHJ bit.ly/3T7nc0z Rocco Montone EHJ Editor-in-Chief
In patients with HFpEF and iron deficiency, intravenous ferric carboxymaltose improved 6-min walking test distance and was associated with fewer serious adverse events. Read the FAIR-HFpEF trial in #EHJ ๐ bit.ly/3XhDc2G Rocco Montone EHJ Editor-in-Chief
In memoriam: Akira Endo. He discovered the statins with a profound impact on public health by significantly reducing the risk of heart attacks and strokes. bit.ly/4fUXCpz #EHJ Rocco Montone EHJ Editor-in-Chief
Optical coherence tomography predictors of clinical outcomes after stent implantation: the ILUMIEN IV trial. Read more in #EHJ ๐ bit.ly/3ABWpDd Rocco Montone EHJ Editor-in-Chief Ziad Ali Gregg W. Stone MD
Honored to have received this unique award directly from EHJ Editor-in-Chief This shows the incredible commitment of European Society of Cardiology Journals for the team โค๏ธ Alessia Gimelli Julia Grapsa EAPCIPresident Univ.-Prof. Dr. Ralph Stephan von Bardeleben Philipp Lurz Giuseppe Biondi-Zoccai Vladyslav Kavalerchyk ๐บ๐ฆ Victoria Delgado European Society of Cardiology
European Society of Cardiology: the 2023 Atlas of Cardiovascular Disease Statistics just published in #EHJ bit.ly/3X3A8Ga Rocco Montone EHJ Editor-in-Chief
Micro-nanoplastics and cardiovascular diseases: evidence and perspectives. A State-of-the-Art Review just published in #EHJ ๐ bit.ly/4cTuBYF Rocco Montone EHJ Editor-in-Chief
Vulnerable plaque and major adverse cardiovascular events: anatomy of a failure. Read this editorial published in #EHJ ๐ bit.ly/4gkeQww Rocco Montone EHJ Editor-in-Chief